piracetam has been researched along with carnitine in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Bono, G; Costa, A; Iannuccelli, M; Mauri, M; Merlo, P; Nappi, G; Sinforiani, E | 1 |
| Costa, RA; de Souza-Pinto, NC; Fernandes, MP; Vercesi, AE | 1 |
| Arroyo Pérez, R; Fernández-Candil, JL; León Jorba, A; Pacreu Terradas, S; Villalba Martínez, G; Vivanco-Hidalgo, RM | 1 |
| de Almeida Magalhães, JC; De Nucci, G; Gagliano-Jucá, T; Lopes, AG; Mendes, GD; Motta, RH; Ramacciato, JC; Silveira, AS; Zaffalon, GT | 1 |
| Chen, WS; Liao, WH; Wu, CH | 1 |
| Antunes, NJ; Campos, R; De Nucci, G; Dezena, RMB; Ilha, J; Mendes, GD; Moreno, RA; Rosa, PCP | 1 |
7 other study(ies) available for piracetam and carnitine
| Article | Year |
|---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Neuropsychological changes in demented patients treated with acetyl-L-carnitine.
Topics: Acetylcarnitine; Aged; Brain Ischemia; Carnitine; Dementia; Female; Humans; Male; Middle Aged; Piracetam; Psychiatric Status Rating Scales; Psychomotor Performance | 1990 |
Protective effects of l-carnitine and piracetam against mitochondrial permeability transition and PC3 cell necrosis induced by simvastatin.
Topics: Carnitine; Cell Line, Tumor; Cyclosporine; Drug Synergism; Humans; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Necrosis; Piracetam; Simvastatin; Superoxides | 2013 |
Ammonia encephalopathy and awake craniotomy for brain language mapping: cause of failed awake craniotomy.
Topics: Anesthesia, General; Anesthesia, Local; Anticonvulsants; Aphasia; Benzodiazepines; Brain Diseases; Brain Mapping; Brain Neoplasms; Carnitine; Clobazam; Conscious Sedation; Consciousness Disorders; Craniotomy; Dominance, Cerebral; Frontal Lobe; Glioma; Humans; Hyperammonemia; Hypnotics and Sedatives; Intraoperative Complications; Language; Levetiracetam; Male; Middle Aged; Piperidines; Piracetam; Propofol; Remifentanil; Seizures; Temporal Lobe; Valproic Acid | 2015 |
Assessment of pharmacokinetic interaction between piracetam and l-carnitine in healthy subjects.
Topics: Administration, Oral; Adolescent; Adult; Biological Availability; Carnitine; Chromatography, High Pressure Liquid; Female; Healthy Volunteers; Humans; Limit of Detection; Male; Middle Aged; Neuroprotective Agents; Piracetam; Spectrometry, Mass, Electrospray Ionization; Tablets; Tandem Mass Spectrometry; Young Adult | 2016 |
Pre-Treatment with Either L-Carnitine or Piracetam Increases Ultrasound-Mediated Gene Transfection by Reducing Sonoporation-Associated Apoptosis.
Topics: Animals; Apoptosis; Carnitine; Cell Membrane Permeability; Cell Survival; Cells, Cultured; Mice; Mice, Inbred BALB C; Nootropic Agents; Piracetam; Transfection; Ultrasonic Waves | 2018 |
Pharmacodynamic evaluation of L-carnitine and piracetam in muscle injury induced by the chronic use of simvastatin.
Topics: Alanine Transaminase; Aspartate Aminotransferases; Carnitine; Humans; Male; Piracetam; Simvastatin | 2020 |